PMCF Study for Partial Vision Restoration Using the Subretinal Implant RETINA IMPLANT Alpha AMS
NCT02588430 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2019-04-19
Summary
This study is a post-market clinical follow-up (PMCF) study to monitor the safety, lifetime and efficacy of patients using the CE-certified RETINA IMPLANT Alpha AMS.
Conditions
Sponsors & Collaborators
-
Retina Implant AG
lead INDUSTRY
Principal Investigators
-
Florian Gekeler, Prof Dr med · Katharinenhospital Stuttgart
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-31
- Primary Completion
- 2029-12-31
- Completion
- 2030-06-30
Countries
- Germany
Study Locations
More Related Trials
-
Efficacy of Cultivated Corneal Epithelial Stem Cell for Ocular Surface Reconstruction
NCT01237600 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Management of Retinitis Pigmentosa by Mesenchymal Stem Cells by Wharton's Jelly Derived Mesenchymal Stem Cells
NCT04224207 ·Status: COMPLETED ·Phase: PHASE3
-
Comparative Study of 1000 Centistoke Versus 5000 Centistoke Silicone Oil for Repair of Complex Retinal Detachments
NCT01255293 ·Status: COMPLETED ·Phase: NA
-
Treatment of PED With AMT and Autologous Serum
NCT00238862 ·Status: COMPLETED ·Phase: NA
-
Treatment of Chronic Central Serous Chorioretinopathy Via Electromagnetic Stimulation and Platelet- Rich Plasma
NCT04224831 ·Status: COMPLETED ·Phase: NA
-
Resorbable Polymer Plates in Repair of Blowout Orbital Floor Fractures
NCT03683615 ·Status: UNKNOWN ·Phase: NA
-
Safety Study of a Sutureless Amniotic Membran Transplantation to Treat Ocular Surface Disorders (Expanded Access)
NCT02168790 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Use of a Biological Lens of Amniotic Membrane (LV-Visio-AMTRIX) in the Treatment of Trophic Ulcers
NCT05172349 ·Status: WITHDRAWN ·Phase: PHASE2
-
Pivotal Trial for a Synthetic Tissue Substitute for Concealment of Artificial Ocular Implants
NCT05469867 ·Status: TERMINATED ·Phase: NA
-
Transcorneal Electrical Stimulation for the Treatment of Retinitis Pigmentosa - a Safety and Efficacy Multicenter Study
NCT02548572 ·Status: WITHDRAWN ·Phase: NA
-
Corneal Epithelium Repair and Therapy Using Autologous Limbal Stem Cell Transplantation
NCT02148016 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Multicenter Study of CAOMECS Transplantation to Patients With Total Limbal Stem Cell Deficiency
NCT01489501 ·Status: WITHDRAWN ·Phase: PHASE3
-
Attention to Retinoblastoma Diagnosed in the Trauma Setting
NCT03764930 ·Status: COMPLETED
-
Healing of Persistent Epithelial Defects
NCT02395952 ·Status: WITHDRAWN ·Phase: NA
-
Acupuncture for the Treatment of Vision Loss Due to Retinitis Pigmentosa
NCT01604356 ·Status: COMPLETED ·Phase: PHASE1
-
The Use of Natural Latex Biomembrane in Ocular Surface Reconstruction
NCT01250353 ·Status: COMPLETED ·Phase: PHASE2
-
Safety Study in Retinal Transplantation for Retinitis Pigmentosa.
NCT00345917 ·Status: COMPLETED ·Phase: PHASE2
-
Investigation of Therapeutic Efficacy and Safety of UMSCs for the Management of Retinitis Pigmentosa (RP)
NCT04763369 ·Status: UNKNOWN ·Phase: PHASE2
-
PXL-Platinum 330 in Eyes With Corneal Thinning Conditions
NCT05489510 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Transplantation of Tissue Cultured Human Amniotic Epithelial Cells Onto Damaged Ocular Surfaces
NCT00344708 ·Status: WITHDRAWN ·Phase: NA
-
First-In-Man Study for an Ophthalmic Synthetic Tissue Substitute
NCT04037917 ·Status: TERMINATED ·Phase: NA
-
Limbus-derived Stem Cells for Prevention of Postoperative Corneal Haze
NCT03295292 ·Status: UNKNOWN ·Phase: PHASE1
-
The Application of Cultured Cornea Stem Cells in Patients Suffering From Corneal Stem Cell Insufficiency
NCT01377311 ·Status: TERMINATED ·Phase: PHASE1
-
Autologous Fat Grafting With PRP (Platelet Rich Plasma) to Anophthalmic Sockets
NCT01712555 ·Status: COMPLETED ·Phase: NA
-
Safety and Effectiveness of the RHCIII-MPC Biosynthetic Cornea in Patients Requiring Anterior Lamellar Keratoplasty
NCT02424006 ·Status: COMPLETED ·Phase: NA